RNA (ribonucleic acid) is a molecule that has been recognized for its many important roles relating to the genetic information of living beings. Nonetheless, since its discovery associated with DNA, it has continued to be a source of quite extraordinary news due to its diversity of forms and involvement in many biological phenomena, such as the origin of life, the transfer of information from DNA, protein synthesis, regulation of gene activity, its catalytic role, the genome of viruses, etc.
Its primary structure is simpler than that of DNA, since it is a polymer made up of a series of nucleotides containing ribose sugars attached to nitrogenous bases and phosphate groups. It differs from DNA in that the thymine base found in DNA is replaced by uracil in RNA, maintaining the other three bases (adenine, guanine and cytosine) in common; it also contains the sugar ribose instead of deoxyribose. The secondary structures usually consist of simple molecules (single-stranded), with considerable variation in sizes and shapes in terms of their secondary or 3D structure by base pairing between regions. They may or may not possess the ability to replicate or generate DNA molecules, or to carry genetic information that can be translated into proteins.
RNA became a focus of attention by geneticists, microbiologists and molecular biologists from the outset, taking center stage in major discoveries in the “Nobel” history of genetics, to use the fortunate expression of professor of genetics Juan Ramón Lacadena (n. 1934). [1]
The discovery and early findings of RNA
RNA also featured in the discovery of the “genetic code”. The Spanish biochemist Severo Ochoa (1905-1993), winner of the Nobel Prize in Medicine in 1959, would contribute to this first of all by the discovery of an enzyme, “polynucleotide phosphorylase”, which can synthesize RNA in vitro. Using this, small RNA molecules could be synthesized that serve to link the combinations of nucleotide bases that correspond to each amino acid. In this way, several geneticists and biochemists, such as the Americans Marshall Nirenberg (1927-2010) and Robert W. Holley (1922-1993) and the Bengali Har Gobind Khorana (1922-2011) deciphered the universal “genetic code” by which the language of genes is translated into the amino acid sequence of proteins, earning them the 1968 Nobel Prize in Medicine.
A year earlier, the American geneticists Howard Temin (1934-1994) and David Baltimore (b. 1938), winners of the 1975 Nobel Prize in Medicine, discovered another enzyme, “reverse transcriptase”, which allows the reverse synthesis of DNA from RNA.
In 1977, the English biochemist Frederick Sanger (1918-2013), the only researcher to win two Nobel prizes in Chemistry (1958 and 1980), presented a method for sequencing RNA.
The RNA molecule has continued to feature in many momentous discoveries. Its starring role is its participation in the process of protein synthesis using three types of components: mRNA, which carries information from the DNA of the genes to the ribosomes, organelles found in the cell cytoplasm; tRNA, which transports amino acids for assembly one by one using the information in the mRNA, according to the genetic code (every three bases codes for one amino acid); and ribosomal RNA (rRNA), a component of ribosomes, organelles of the cell cytoplasm on which protein synthesis occurs.
More recently, in the 1980s, a new functional role for RNA was discovered: as a regulator of gene expression. A regulatory mechanism discovered by the French geneticists François Jacob (1920-2013) and Jacques Monod (1910-1976), winners of the 1965 Nobel Prize in Medicine, had been previously known by scientists since the 1960s, and thousands of transcription factors that cause genes to be expressed had been identified. It was also believed that the basic principles of genetic regulation had been resolved. In the 1980s, however, American researchers Victor Ambros (b. 1953) and Gary Ruvkun (b. 1952), recently awarded the 2024 Nobel Prize in Medicine, would discover a new mechanism that operates in the nematode worm Caenorhabditis elegans, interfering with the function of mRNAs, [2, 3] as we explained in our previous article “Ambros and Ruvkun awarded the 2024 Nobel Prize in Medicine for their research on microRNA” on the Bioethics Observatory website.
Other types of RNA, small nuclear RNAs, are responsible for processing messenger RNAs before their translation into proteins, removing the “introns” (non-coding areas).
Did RNA play an important role in the origin of life?
It is impossible to reproduce the conditions under which the first living beings that inhabited the Earth would have formed, our “cenancesters” of more than 3.6 billion years ago, and uncovering the origin of the organic biomolecules that make up living beings remains a chapter full of unknowns. Nevertheless, RNA also plays a special role in this important and difficult issue.
In the late 1960s, British biochemists Francis Crick and Leslie Orgel (1927–2007) and American microbiologist Carl Woese (1928–2012) independently suggested that the genetic information in the most primitive living things might consist of RNA molecules. Years later, the Canadian Sidney Altman (1938-2022) and the American Thomas Cech (b. 1947) discovered a type of catalytic RNA, i.e., capable of accelerating chemical reactions as if it were an enzyme, in various present-day living beings, so it was agreed to call these molecules “ribozymes”. They received the 1989 Nobel Prize in Chemistry for this finding.
Ribozymes are a type of RNA molecule that folds into a complex tertiary structure and can catalyze protein synthesis. They have in themselves a dual mission: to carry information and to catalyze reactions. Therefore, since both types of molecules need each other, in a way they allow us to resolve the question of which came first: nucleic acids or proteins? the chicken or the egg? Nucleic acids carry the information needed to make proteins, but proteins are required to catalyze nucleic acid synthesis. Perhaps in the beginning there was only RNA and the impetus towards the first organisms would occur when it was replaced by DNA, a more stable and complex molecule whose double-stranded structure would facilitate replication, while the catalytic function would be carried out by proteins.
RNA as a defense mechanism
More recently, we have learned about the role of RNA as a component of a defense mechanism in bacteria and archaea. Their genome contains the CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) region discovered by the Spanish microbiologist Francis Mojica, which acts in these microorganisms as an immune system, involved in the destruction of the invading DNA.
To that end, small RNA molecules are synthesized from this region which, together with a nuclease enzyme called Cas, will destroy foreign DNA after its recognition by base complementation.[4, 5] Based on this discovery, the American biochemist Jennifer Doudna (b. 1964) and the French microbiologist Emmanuelle Charpentier (b. 1968) patented a procedure for “gene editing”, CRISPR-Cas9, for use in gene therapy, for which they were awarded the 2020 Nobel Prize in Chemistry.[6] This extraordinary breakthrough was the subject of the conference “Genetic research: possibilities and risks” held in Valencia in June 2014 by the Bioethics Observatory of the Catholic University of Valencia.
RNA vaccines
From RNA viruses to viroids
Viruses are very simple microorganisms that consist of a DNA or RNA molecule and a protein coat encoded by their own genome, but whose cycle is dependent on the metabolic system of the cells they must necessarily parasitize. There are a number of viruses that have an RNA genome with a single strand and free ends, such as coronaviruses, rhinoviruses and retroviruses, which can also cause human, animal and plant diseases. These viruses are characterized by their high mutation rate, which complicates the fight against them. The smallest known RNA viruses have about 2000 nucleotide bases that contain the minimum information necessary for their simple life cycle.
In the late sixties, the American microbiologist Theodor Diener (1921-2023), working at the USDA (United States Department of Agriculture) Plant Virology Laboratory in Beltsville (Maryland), determined that an infectious agent of unknown etiology that affected the potato crop, with symptoms similar to a virus, was not really a virus. Rather, it was something even simpler and smaller, composed of an RNA molecule about 10 times smaller than viral RNAs and without proteins, self-replicating, so he called them “viroids”.[7] Electron microscopy revealed that they are RNA molecules of about 200-300 bases, circular and folded in on themselves by base complementarity as their ends are joined, giving them a rod-like appearance.
Since then, dozens of viroids have been discovered that infect cells of many plant species. These are classified into two families, Pospiviroidae and Avsunviroidae, depending on whether or not they contain a conserved region in their genome.
Moreover, of great interest was Diener’s 1989 suggestion that viroids and other viroid-like satellite RNAs may be “living fossils” of a precellular RNA world,[8] a remarkable suggestion that brings us closer to knowing the origin of life.
And now, the RNA “obelisks” in our microbiome
The human microbiome contains an incredible diversity of microorganisms, including viruses, bacteria, fungi and protozoa. They constitute an intricate world of organisms that reside in our organs and tissues and that perform crucial functions for digestion, the immune system and other roles of great importance for health. They are generally beneficial and are found in many organs of the human body.
Obelisks lack the protein coat that characterizes viruses, and are reminiscent of viroids, with which they share a circular RNA genome, albeit larger in size. The main difference is that they synthesize the aforementioned oblins. Thus, in terms of their organization, obelisks are a type of structure somewhere between viruses and viroids.
This discovery is the result of a bioinformatic study of the types of nucleic acid molecules present in the human microbiome. It has identified nearly 30,000 types of obelisks in biological samples collected from humans as well as from numerous sources and ecosystems, including wastewater and animal samples. Among all these, an obelisk from the human oral microbiome found in the common mouth bacterium Streptococcus sanguinis has been characterized.
They were discovered by American, Canadian and Spanish researchers, including Dr. Marcos de la Peña of the Institute of Plant Molecular and Cellular Biology at the Polytechnic University of Valencia and the CSIC, as well as winner of the 2006 Nobel Prize in Medicine, the American biologist Andrew Fire (b. 1959), who participated in the discovery of RNA interference, involved in gene silencing. According to the discoverers, obelisks form their own phylogenetic group with no detectable similarity to known biological agents. It is a very diverse class of RNA that has colonized and gone unnoticed in all previous studies on human and global microbiomes, and whose biological role has yet to be determined.
This discovery raises questions about the origin and evolution of microbiological diversity. The role and effects of obelisks and the proteins they encode is still a mystery, but it is clear that they must exercise some important function given their high presence in the bacteria of our microbiome where they live. Similarly, it is important to know their effects on human health.
In short, the study of RNA is an ever-evolving field that continues to offer new avenues of research and applications, which may allow us to unravel the still unsolved mystery of the origin of life and its extraordinary diversification.
Nicolás Jouve
Professor Emeritus of Genetics at the University of Alcalá
Member of the Bioethics Observatory
References:
[1] Lacadena, J. R. Conmemorando los 100 años del término genética (1905-2005): Una historia «Nobelada» de la Genética. Publicaciones Universidad de León; N.º 1 edición (1 septiembre 2007)
[2] Lee RC, Feinbaum RL, Ambros V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell. 1993,
[3] Wightman B, Ha I, Ruvkun G. Posttranscriptional regulation of the heterochronic gene lin-14 by lin-4 mediates temporal pattern formation in C. elegans. Cell. 1993, 75(5) 855-862.
[4] Ishino Y, Shinagawa H, Makino K, Amemura M, Nakata A. Nucleotide sequence of the iap gene, responsible for alkaline phosphatase isozyme conversion in Escherichia coli, and identification of the gene product. J Bacteriol. 1987 169(12): 5429-5433.
[5] Mojica FJ, Ferrer C, Juez G, Rodríguez-Valera F. Long stretches of short tandem repeats are present in the largest replicons of the Archaea Haloferax mediterranei and Haloferax volcanii and could be involved in replicon partitioning. Mol Microbiol. 1995 Jul;17(1):85-93.
[6] Doudna JA, Charpentier, E. Genome editing. The new frontier of genome engineering with CRISPR-Cas9. Science 2014;346 (6213):1258096
[7] Diener T.O., Raymer W.B. Potato spindle tuber virus: A plant virus with properties of a free nucleic acid. Science. 1967;158:378–381.
[8] Diener T.O. Circular RNAs: Relics of precellular evolution? Proc. Natl. Acad. Sci. USA 1989;86:9370–9374. doi: 10.1073/pnas.86.23.9370.
[9] Zheludev IN, Edgar RC, Lopez-Galiano MJ, de la Peña M, Babaian A, Bhatt AS, Fire AZ. Viroid-like colonists of human microbiomes. Cell. DOI: doi.org/10.1016/j.cell.2024.09.033